UnknownPHASE2, PHASE3NCT04597775

Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Regional Center for Disease Control and Prevention, Jordan
Principal Investigator
Munir Abu-Helalah, PHD
Regional Center for Disease Control
Intervention
hydroxychloroquine(drug)
Enrollment
93 target
Eligibility
18-65 years · All sexes
Timeline
20202021

Collaborators

Farhat Hached Hospital, Tunisia · Fattouma Bourguiba, Tunisia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04597775 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials